fbpx

< Back to Thought Leadership

Occupational Mix Survey Deadline Extended

CMS has granted an extension for hospitals nationwide to file their Occupational Mix Surveys (OMS). The original due date of July 1, 2020, has been extended to August 3, 2020.

Every three years, the Centers for Medicare and Medicaid Services (CMS) requires any hospital that is subject to the Inpatient Prospective Payment System (IPPS) to complete an OMS. The data collected from these surveys is used to calculate the Occupational Mix Adjustment Factors (OMAF) which will affect your FFY 2022, 2023, and 2024 DRG and APC rates.

Since the survey is only required once every three years, we find that many hospitals have questions about the impact the Occupational Mix Surveys can have on their reimbursement or how CMS uses the surveys. Many times we find that the surveys have been completed inaccurately or are incomplete. In order to optimize your hospital’s reimbursement, it is crucial for your hospital to identify the areas of opportunity and understand how the data needs to be reported.

We would appreciate the opportunity to assist your hospital to identify opportunities and to develop strategies while completing this survey. Please contact Kyle Smith with any questions.

Share this article

No Tax on Tips and Overtime? The One Big Beautiful Bill Explained for Employers

The One Big Beautiful Bill brings sweeping changes to employer reporting and compensation practices — and understanding the details is critical to avoiding costly mistakes. In this recorded webinar, Blue […]

Learn More
accounting for tariffs

Accounting for Tariffs: Inventory Implications and Strategic Considerations

By Patrick Brown, CPA, Director of Manufacturing Services at Blue & Co. Industries around the world, particularly those that rely on imported products, continue to face challenges related to tariffs. […]

Learn More
New 340B Rebate Model Pilot Program: What to Know

New 340B Rebate Model Pilot Program: What to Know

The Health Resources and Services Administration (HRSA) has approved a 340B Rebate Model Pilot Program that will significantly change how 340B discounts are accessed for covered entities for certain medications.  […]

Learn More
Share this article
Share this article